Clinical and MRI improvement in a case of progressive multifocal leukoencephalopathy

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Weissert R (2011) Progressive multifocal leukoencephalopathy. J Neuroimmunol 23:73–77

    Article  Google Scholar 

  2. 2.

    Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, Bartt R, Major EO, Nath A (2013) PML diagnostic criteria. Consensus statement from the AAN neuroinfectious disease section. Neurology 80:1430–1438

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72:1458–1464

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Reilmann R, Imai T, Ringelstein EB, Gaubitz M, Niederstadt TU, Paulus W, Husstedt IW (2005) Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. J Neurol Neurosurg Psychiatry 76:1304–1305

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9:438–446

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

Authors gratefully thank Doctor Daniele Giuseppe Romano for his help in the brain MRI evaluation.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alessandra Rufa.

Ethics declarations

Conflict of interest

None. All authors have approved the final article. Patient’s anonymity was protected in this case report.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tirelli, L., Rosini, F., Rufa, A. et al. Clinical and MRI improvement in a case of progressive multifocal leukoencephalopathy. Neurol Sci 38, 1517–1519 (2017). https://doi.org/10.1007/s10072-017-2914-9

Download citation

Keywords

  • Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Patient
  • Progressive Multifocal Leukoencephalopathy
  • Mirtazapine
  • Natalizumab